200 related articles for article (PubMed ID: 18782836)
1. Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women.
Chan KY; Liu W; Long JR; Yip SP; Chan SY; Shu XO; Chua DT; Cheung AN; Ching JC; Cai H; Au GK; Chan M; Foo W; Ngan HY; Gao YT; Ngan ES; Garcia-Barceló MM; Zheng W; Khoo US
J Med Genet; 2009 Jan; 46(1):32-9. PubMed ID: 18782836
[TBL] [Abstract][Full Text] [Related]
2. A BRCA1 promoter variant (rs11655505) and breast cancer risk.
Verderio P; Pizzamiglio S; Southey MC; Spurdle AB; Hopper JL; Chen X; Beesley J; ; Schmutzler RK; Engel C; Burwinkel B; Bugert P; Ficarazzi F; Manoukian S; Barile M; Wappenschmidt B; Chenevix-Trench G; Radice P; Peterlongo P
J Med Genet; 2010 Apr; 47(4):268-70. PubMed ID: 20413709
[TBL] [Abstract][Full Text] [Related]
3. Association of the BRCA1 promoter polymorphism rs11655505 with the risk of familial breast and/or ovarian cancer.
Bielinska B; Gaj P; Kluska A; Nowakowska D; Balabas A; Dabrowska M; Niwinska A; Gruchota J; Zub R; Skasko E; Steffen J; Ostrowski J; Siedlecki JA
Fam Cancer; 2013 Dec; 12(4):691-8. PubMed ID: 23657760
[TBL] [Abstract][Full Text] [Related]
4. Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer.
Hasan TN; Leena Grace B; Shafi G; Syed R
Clin Transl Oncol; 2013 Jul; 15(7):555-62. PubMed ID: 23263908
[TBL] [Abstract][Full Text] [Related]
5. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.
Cox DG; Simard J; Sinnett D; Hamdi Y; Soucy P; Ouimet M; Barjhoux L; Verny-Pierre C; McGuffog L; Healey S; Szabo C; Greene MH; Mai PL; Andrulis IL; ; Thomassen M; Gerdes AM; Caligo MA; Friedman E; Laitman Y; Kaufman B; Paluch SS; Borg Å; Karlsson P; Askmalm MS; Bustinza GB; ; Nathanson KL; Domchek SM; Rebbeck TR; Benítez J; Hamann U; Rookus MA; van den Ouweland AM; Ausems MG; Aalfs CM; van Asperen CJ; Devilee P; Gille HJ; ; ; Peock S; Frost D; Evans DG; Eeles R; Izatt L; Adlard J; Paterson J; Eason J; Godwin AK; Remon MA; Moncoutier V; Gauthier-Villars M; Lasset C; Giraud S; Hardouin A; Berthet P; Sobol H; Eisinger F; Bressac de Paillerets B; Caron O; Delnatte C; ; Goldgar D; Miron A; Ozcelik H; Buys S; Southey MC; Terry MB; ; Singer CF; Dressler AC; Tea MK; Hansen TV; Johannsson O; Piedmonte M; Rodriguez GC; Basil JB; Blank S; Toland AE; Montagna M; Isaacs C; Blanco I; Gayther SA; Moysich KB; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Ditsch N; Arnold N; Niederacher D; Sutter C; Gadzicki D; Fiebig B; Caldes T; Laframboise R; Nevanlinna H; Chen X; Beesley J; Spurdle AB; Neuhausen SL; Ding YC; Couch FJ; Wang X; Peterlongo P; Manoukian S; Bernard L; Radice P; Easton DF; Chenevix-Trench G; Antoniou AC; Stoppa-Lyonnet D; Mazoyer S; Sinilnikova OM;
Hum Mol Genet; 2011 Dec; 20(23):4732-47. PubMed ID: 21890493
[TBL] [Abstract][Full Text] [Related]
6. [Effect of R264C polymorphism in CYP19A1 gene on BRCA1/2-negative hereditary breast cancer from Shanghai population of China].
Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):181-3. PubMed ID: 16604491
[TBL] [Abstract][Full Text] [Related]
7. Genetic evaluation of BRCA1 associated a complex genes with triple-negative breast cancer susceptibility in Chinese women.
Ling H; Li S; Wu Y; Zheng YZ; Qiao F; Yao L; Cao ZG; Ye FG; Wu J; Hu X; Wang B; Shao ZM
Oncotarget; 2016 Mar; 7(9):9759-72. PubMed ID: 26848770
[TBL] [Abstract][Full Text] [Related]
8. Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53.
Yu KD; Di GH; Yuan WT; Fan L; Wu J; Hu Z; Shen ZZ; Zheng Y; Huang W; Shao ZM
Hum Mol Genet; 2009 Jul; 18(13):2502-17. PubMed ID: 19351655
[TBL] [Abstract][Full Text] [Related]
9. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.
Kataoka N; Cai Q; Wen W; Shu XO; Jin F; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1148-52. PubMed ID: 16775174
[TBL] [Abstract][Full Text] [Related]
10. Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.
Kwong A; Ng EK; Wong CL; Law FB; Au T; Wong HN; Kurian AW; West DW; Ford JM; Ma ES
PLoS One; 2012; 7(9):e43994. PubMed ID: 22970155
[TBL] [Abstract][Full Text] [Related]
11. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
[TBL] [Abstract][Full Text] [Related]
12. Functional polymorphisms in CD166/ALCAM gene associated with increased risk for breast cancer in a Chinese population.
Zhou P; Du LF; Lv GQ; Yu XM; Gu YL; Li JP; Zhang C
Breast Cancer Res Treat; 2011 Jul; 128(2):527-34. PubMed ID: 21293922
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations.
de Bruin MA; Kwong A; Goldstein BA; Lipson JA; Ikeda DM; McPherson L; Sharma B; Kardashian A; Schackmann E; Kingham KE; Mills MA; West DW; Ford JM; Kurian AW
Fam Cancer; 2012 Sep; 11(3):429-39. PubMed ID: 22638769
[TBL] [Abstract][Full Text] [Related]
14. Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population.
Kong F; Liu J; Liu Y; Song B; Wang H; Liu W
J Exp Clin Cancer Res; 2010 Jun; 29(1):72. PubMed ID: 20553628
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in Punjabi population from North West India.
Kapahi R; Guleria K; Sambyal V; Manjari M; Sudan M; Uppal MS; Singh NR
Tumour Biol; 2014 Nov; 35(11):11171-81. PubMed ID: 25106408
[TBL] [Abstract][Full Text] [Related]
16. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients.
Su L; Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
Int J Cancer; 2020 Jun; 146(12):3335-3342. PubMed ID: 32037537
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predisposition.
Dos Santos ES; Caputo SM; Castera L; Gendrot M; Briaux A; Breault M; Krieger S; Rogan PK; Mucaki EJ; Burke LJ; ; Bièche I; Houdayer C; Vaur D; Stoppa-Lyonnet D; Brown MA; Lallemand F; Rouleau E
Breast Cancer Res Treat; 2018 Apr; 168(2):311-325. PubMed ID: 29236234
[TBL] [Abstract][Full Text] [Related]
18. MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ
Breast Cancer Res Treat; 2008 Oct; 111(3):497-504. PubMed ID: 18026875
[TBL] [Abstract][Full Text] [Related]
19. Association analysis of interleukin-18 gene promoter region polymorphisms and susceptibility to sporadic breast cancer in Chinese Han women.
Qiao X; Xu D; Sun D; Sun S; Huang Z; Cui W
J Clin Lab Anal; 2018 Nov; 32(9):e22591. PubMed ID: 29926984
[TBL] [Abstract][Full Text] [Related]
20. Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population.
Wang L; Li D; Fu Z; Li H; Jiang W; Li D
BMC Cancer; 2007 Sep; 7():173. PubMed ID: 17825114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
